- Lobbying
- Lobbying by TAP Pharmaceutical Products
Lobbying Relationship
Bills mentioned
S.2668: Reducing Fraudulent and Imitation Drugs Act of 2006
Sponsor: David Vitter (R-La.)
H.R.4829: Reducing Fraudulent and Imitation Drugs Act of 2006
Sponsor: Dan Burton (R-Ind.)
H.R.5156: Counterfeit Drug Prevention Act of 2006
Sponsor: Mike Rogers (R-Mich.)
H.R.5465: Comprehensive Cancer Care Improvement Act of 2006
Sponsor: Lois Capps (D-Calif.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Laura Cline E. | n/a |
Deborah Walter L. | n/a |
Laura Cline | n/a |
Deborah Walter | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate